BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19861768)

  • 1. Enterocutaneous fistula.
    Ajao OG; Shehri MY
    Saudi J Gastroenterol; 2001 May; 7(2):51-4. PubMed ID: 19861768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M; Ahmed U; Sobia H
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition and management of enterocutaneous fistula.
    Lloyd DA; Gabe SM; Windsor AC
    Br J Surg; 2006 Sep; 93(9):1045-55. PubMed ID: 16804873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V; Felekis D; Zorbalas A
    Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterocutaneous fistula: are treatments improving?
    Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma.
    Spiliotis J; Briand D; Gouttebel MC; Astre C; Louer B; Saint-Aubert B; Kalfarentzos F; Androulakis J; Joyeux H
    Surg Gynecol Obstet; 1993 Jun; 176(6):575-80. PubMed ID: 8322132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of a hospital experience of enterocutaneous fistula.
    Kaur N; Minocha VR
    Trop Gastroenterol; 2000; 21(4):197-200. PubMed ID: 11194587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment results of enterocutaneous fistulae in patients with cancer].
    González-Avila G; Quezada-Ramírez ME; Jiménez Pardo E; Bello-Villalobos H
    Rev Gastroenterol Mex; 2005; 70(2):158-63. PubMed ID: 16167491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative entero-cutaneous fistula].
    Martínez-Ordaz JL; Luque-de-León E; Suárez-Moreno RM; Blanco-Benavides R
    Gac Med Mex; 2003; 139(2):144-51. PubMed ID: 12754949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only.
    Spiliotis J; Vagenas K; Panagopoulos K; Kalfarentzos F
    Br J Clin Pract; 1990 Dec; 44(12):616-8. PubMed ID: 1983231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of enterocutaneous fistulas with parenteral hyperalimentation.
    Alhan E; Calik A; Kucuktulu U
    Z Gastroenterol; 1993 Nov; 31(11):657-60. PubMed ID: 8291277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment.
    Dárdai E; Pirityi S; Nagy L
    Acta Chir Hung; 1991; 32(4):305-18. PubMed ID: 1844622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten-year review of enterocutaneous fistulas after laparotomy for trauma.
    Fischer PE; Fabian TC; Magnotti LJ; Schroeppel TJ; Bee TK; Maish GO; Savage SA; Laing AE; Barker AB; Croce MA
    J Trauma; 2009 Nov; 67(5):924-8. PubMed ID: 19901649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes and management of postoperative enterocutaneous fistulas.
    Memon AS; Siddiqui FG
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 11-year experience of enterocutaneous fistula.
    Hollington P; Mawdsley J; Lim W; Gabe SM; Forbes A; Windsor AJ
    Br J Surg; 2004 Dec; 91(12):1646-51. PubMed ID: 15505866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas.
    Mawdsley JE; Hollington P; Bassett P; Windsor AJ; Forbes A; Gabe SM
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1111-21. PubMed ID: 18671774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
    Chen RJ; Fang JF; Chen MF
    Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. I. Investigations on fistula output, nutritional status complications.
    Dárdai E; Pirityi S; Nagy L
    Acta Chir Hung; 1991; 32(4):287-303. PubMed ID: 1844621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hypertriglyceridemia in patients with enterocutaneous fistulas.
    Visschers RG; Olde Damink SW; Schreurs M; Winkens B; Soeters PB; van Gemert WG
    Clin Nutr; 2009 Jun; 28(3):313-7. PubMed ID: 19327876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.